Interleukin-17 and interleukin-23 inhibitors in the treatment of pustular psoriasis / 中华皮肤科杂志
Chinese Journal of Dermatology
; (12): 689-692, 2023.
Article
in Zh
| WPRIM
| ID: wpr-994518
Responsible library:
WPRO
ABSTRACT
Pustular psoriasis is a serious life-threatening disease, and patients usually show poor response to traditional treatments. In recent years, interleukin-17 and interleukin-23 inhibitors have shown favorable efficacy in the treatment of psoriasis. This review summarizes the latest progress in interleukin-17 and interleukin-23 inhibitors for the treatment of pustular psoriasis.
Full text:
1
Index:
WPRIM
Language:
Zh
Journal:
Chinese Journal of Dermatology
Year:
2023
Type:
Article